Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study.

Hiniker SM, Sodji Q, Quon A, Gutkin PM, Arksey N, Graves EE, Chin FT, Maxim PG, Diehn M, Loo BW Jr.

Front Oncol. 2019 May 31;9:467. doi: 10.3389/fonc.2019.00467. eCollection 2019.

PMID:
31214507
2.

Increases in Serial Pretreatment 18F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy.

Prionas ND, von Eyben R, Yi E, Aggarwal S, Shaffer J, Bazan J, Eastham D, Maxim PG, Graves EE, Diehn M, Gensheimer MF, Loo BW Jr.

Adv Radiat Oncol. 2018 Nov 26;4(2):429-437. doi: 10.1016/j.adro.2018.11.006. eCollection 2019 Apr-Jun.

3.

[18F]-SuPAR: A Radiofluorinated Probe for Noninvasive Imaging of DNA Damage-Dependent Poly(ADP-ribose) Polymerase Activity.

Shuhendler AJ, Cui L, Chen Z, Shen B, Chen M, James ML, Witney TH, Bazalova-Carter M, Gambhir SS, Chin FT, Graves EE, Rao J.

Bioconjug Chem. 2019 May 15;30(5):1331-1342. doi: 10.1021/acs.bioconjchem.9b00089. Epub 2019 Apr 22.

PMID:
30973715
4.

Analysis of insecticide exposure in California hummingbirds using liquid chromatography-mass spectrometry.

Graves EE, Jelks KA, Foley JE, Filigenzi MS, Poppenga RH, Ernest HB, Melnicoe R, Tell LA.

Environ Sci Pollut Res Int. 2019 May;26(15):15458-15466. doi: 10.1007/s11356-019-04903-x. Epub 2019 Apr 2.

PMID:
30941712
5.

Quantitation of neonicotinoid insecticides, plus qualitative screening for other xenobiotics, in small-mass avian tissue samples using UHPLC high-resolution mass spectrometry.

Filigenzi MS, Graves EE, Tell LA, Jelks KA, Poppenga RH.

J Vet Diagn Invest. 2019 May;31(3):399-407. doi: 10.1177/1040638719834329. Epub 2019 Mar 11.

PMID:
30853007
6.

Integrating Small Animal Irradiators withFunctional Imaging for Advanced Preclinical Radiotherapy Research.

Ghita M, Brown KH, Kelada OJ, Graves EE, Butterworth KT.

Cancers (Basel). 2019 Feb 1;11(2). pii: E170. doi: 10.3390/cancers11020170. Review.

7.

Preclinical Evaluation of Dose-Volume Effects and Lung Toxicity Occurring In and Out-of-Field.

Ghita M, Dunne VL, McMahon SJ, Osman SO, Small DM, Weldon S, Taggart CC, McGarry CK, Hounsell AR, Graves EE, Prise KM, Hanna GG, Butterworth KT.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1231-1240. doi: 10.1016/j.ijrobp.2018.12.010. Epub 2018 Dec 12.

PMID:
30552964
8.

A gold nanoparticle system for the enhancement of radiotherapy and simultaneous monitoring of reactive-oxygen-species formation.

Choi BJ, Jung KO, Graves EE, Pratx G.

Nanotechnology. 2018 Dec 14;29(50):504001. doi: 10.1088/1361-6528/aae272. Epub 2018 Sep 19.

PMID:
30229748
9.

Macrophages Promote Circulating Tumor Cell-Mediated Local Recurrence following Radiotherapy in Immunosuppressed Patients.

Rafat M, Aguilera TA, Vilalta M, Bronsart LL, Soto LA, von Eyben R, Golla MA, Ahrari Y, Melemenidis S, Afghahi A, Jenkins MJ, Kurian AW, Horst KC, Giaccia AJ, Graves EE.

Cancer Res. 2018 Aug 1;78(15):4241-4252. doi: 10.1158/0008-5472.CAN-17-3623. Epub 2018 Jun 7.

PMID:
29880480
10.

18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy.

Qian Y, Von Eyben R, Liu Y, Chin FT, Miao Z, Apte S, Carter JN, Binkley MS, Pollom EL, Harris JP, Prionas ND, Kissel M, Simmons A, Diehn M, Shultz DB, Brown JM, Maxim PG, Koong AC, Graves EE, Loo BW Jr.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1183-1192. doi: 10.1016/j.ijrobp.2018.03.045. Epub 2018 Apr 18.

PMID:
29859786
11.

The tumour microenvironment links complement system dysregulation and hypoxic signalling.

Olcina MM, Kim RK, Melemenidis S, Graves EE, Giaccia AJ.

Br J Radiol. 2018 May 15:20180069. doi: 10.1259/bjr.20180069. [Epub ahead of print]

PMID:
29544344
12.

The role of granulocyte macrophage colony stimulating factor (GM-CSF) in radiation-induced tumor cell migration.

Vilalta M, Brune J, Rafat M, Soto L, Graves EE.

Clin Exp Metastasis. 2018 Apr;35(4):247-254. doi: 10.1007/s10585-018-9877-y. Epub 2018 Mar 13.

13.

Evaluation of Proctophyllodes huitzilopochtlii on feathers from Anna's (Calypte anna) and Black-chinned (Archilochus alexandri) Hummingbirds: Prevalence assessment and imaging analysis using light and tabletop scanning electron microscopy.

Yamasaki YK, Graves EE, Houston RS, OConnor BM, Kysar PE, Straub MH, Foley JE, Tell LA.

PLoS One. 2018 Feb 14;13(2):e0191323. doi: 10.1371/journal.pone.0191323. eCollection 2018.

14.

Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer.

Gensheimer MF, Hong JC, Chang-Halpenny C, Zhu H, Eclov NCW, To J, Murphy JD, Wakelee HA, Neal JW, Le QT, Hara WY, Quon A, Maxim PG, Graves EE, Olson MR, Diehn M, Loo BW Jr.

Radiother Oncol. 2017 Nov;125(2):338-343. doi: 10.1016/j.radonc.2017.08.007. Epub 2017 Aug 19.

PMID:
28830717
15.

BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer.

Chiou SH, Risca VI, Wang GX, Yang D, Grüner BM, Kathiria AS, Ma RK, Vaka D, Chu P, Kozak M, Castellini L, Graves EE, Kim GE, Mourrain P, Koong AC, Giaccia AJ, Winslow MM.

Cancer Discov. 2017 Oct;7(10):1184-1199. doi: 10.1158/2159-8290.CD-17-0250. Epub 2017 Aug 8.

16.

Brief Report: External Beam Radiation Therapy for the Treatment of Human Pluripotent Stem Cell-Derived Teratomas.

Lee AS, Tang C, Hong WX, Park S, Bazalova-Carter M, Nelson G, Sanchez-Freire V, Bakerman I, Zhang W, Neofytou E, Connolly AJ, Chan CK, Graves EE, Weissman IL, Nguyen PK, Wu JC.

Stem Cells. 2017 Aug;35(8):1994-2000. doi: 10.1002/stem.2653. Epub 2017 Jul 10.

17.

Multi-institutional MicroCT image comparison of image-guided small animal irradiators.

Johnstone CD, Lindsay P, Graves EE, Wong E, Perez JR, Poirier Y, Ben-Bouchta Y, Kanesalingam T, Chen H, Rubinstein AE, Sheng K, Bazalova-Carter M.

Phys Med Biol. 2017 Jun 26;62(14):5760-5776. doi: 10.1088/1361-6560/aa76b4.

18.

Feasibility of external beam radiation therapy to deep-seated targets with kilovoltage x-rays.

Bazalova-Carter M, Weil MD, Breitkreutz DY, Wilfley BP, Graves EE.

Med Phys. 2017 Feb;44(2):597-607. doi: 10.1002/mp.12047. Epub 2017 Jan 30.

19.

Reprogramming the immunological microenvironment through radiation and targeting Axl.

Aguilera TA, Rafat M, Castellini L, Shehade H, Kariolis MS, Hui AB, Stehr H, von Eyben R, Jiang D, Ellies LG, Koong AC, Diehn M, Rankin EB, Graves EE, Giaccia AJ.

Nat Commun. 2016 Dec 23;7:13898. doi: 10.1038/ncomms13898.

20.

Dynamic CT imaging of volumetric changes in pulmonary nodules correlates with physical measurements of stiffness.

Lartey FM, Rafat M, Negahdar M, Malkovskiy AV, Dong X, Sun X, Li M, Doyle T, Rajadas J, Graves EE, Loo BW, Maxim PG.

Radiother Oncol. 2017 Feb;122(2):313-318. doi: 10.1016/j.radonc.2016.11.019. Epub 2016 Dec 15.

21.

Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location.

Vilalta M, Hughes NP, Von Eyben R, Giaccia AJ, Graves EE.

Mol Imaging Biol. 2017 Apr;19(2):215-224. doi: 10.1007/s11307-016-1010-5.

22.

Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235.

Bazan JG, Duan F, Snyder BS, Horng D, Graves EE, Siegel BA, Machtay M, Loo BW Jr.

Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):17-24. Epub 2016 Sep 19.

23.

The impact of audiovisual biofeedback on 4D functional and anatomic imaging: Results of a lung cancer pilot study.

Yang J, Yamamoto T, Pollock S, Berger J, Diehn M, Graves EE, Loo BW Jr, Keall PJ.

Radiother Oncol. 2016 Aug;120(2):267-72. doi: 10.1016/j.radonc.2016.05.016. Epub 2016 May 30.

24.

Effects of radiation on metastasis and tumor cell migration.

Vilalta M, Rafat M, Graves EE.

Cell Mol Life Sci. 2016 Aug;73(16):2999-3007. doi: 10.1007/s00018-016-2210-5. Epub 2016 Mar 29. Review.

25.

Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome.

Graves EE, Hicks RJ, Binns D, Bressel M, Le QT, Peters L, Young RJ, Rischin D.

Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):617-25. doi: 10.1007/s00259-015-3247-7. Epub 2015 Nov 18.

26.

Molecular Magnetic Resonance Imaging of Tumor Response to Therapy.

Shuhendler AJ, Ye D, Brewer KD, Bazalova-Carter M, Lee KH, Kempen P, Dane Wittrup K, Graves EE, Rutt B, Rao J.

Sci Rep. 2015 Oct 6;5:14759. doi: 10.1038/srep14759.

27.

18F-EF5 PET Is Predictive of Response to Fractionated Radiotherapy in Preclinical Tumor Models.

Ali R, Apte S, Vilalta M, Subbarayan M, Miao Z, Chin FT, Graves EE.

PLoS One. 2015 Oct 2;10(10):e0139425. doi: 10.1371/journal.pone.0139425. eCollection 2015.

28.

Imaging radiation response in tumor and normal tissue.

Rafat M, Ali R, Graves EE.

Am J Nucl Med Mol Imaging. 2015 Jun 15;5(4):317-32. eCollection 2015. Review.

29.

Understanding the Mechanism of Action of Triazine-Phosphonate Derivatives as Flame Retardants for Cotton Fabric.

Nguyen MM, Al-Abdul-Wahid MS, Fontenot KR, Graves EE, Chang S, Condon BD, Grimm CC, Lorigan GA.

Molecules. 2015 Jun 18;20(6):11236-56. doi: 10.3390/molecules200611236.

30.

Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI.

Zhou H, Hallac RR, Lopez R, Denney R, MacDonough MT, Li L, Liu L, Graves EE, Trawick ML, Pinney KG, Mason RP.

Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):143-53. eCollection 2015.

31.

Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors.

Harris JP, Chang-Halpenny CN, Maxim PG, Quon A, Graves EE, Diehn M, Loo BW Jr.

Clin Lung Cancer. 2015 Nov;16(6):475-85. doi: 10.1016/j.cllc.2015.01.007. Epub 2015 Jan 31.

32.

Recruitment of circulating breast cancer cells is stimulated by radiotherapy.

Vilalta M, Rafat M, Giaccia AJ, Graves EE.

Cell Rep. 2014 Jul 24;8(2):402-9. doi: 10.1016/j.celrep.2014.06.011. Epub 2014 Jul 10.

33.
34.

The potential of positron emission tomography for intratreatment dynamic lung tumor tracking: a phantom study.

Yang J, Yamamoto T, Mazin SR, Graves EE, Keall PJ.

Med Phys. 2014 Feb;41(2):021718. doi: 10.1118/1.4861816.

35.

Modality comparison for small animal radiotherapy: a simulation study.

Bazalova M, Nelson G, Noll JM, Graves EE.

Med Phys. 2014 Jan;41(1):011710. doi: 10.1118/1.4842415.

36.

Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary.

Wallner PE, Anscher MS, Barker CA, Bassetti M, Bristow RG, Cha YI, Dicker AP, Formenti SC, Graves EE, Hahn SM, Hei TK, Kimmelman AC, Kirsch DG, Kozak KR, Lawrence TS, Marples B, McBride WH, Mikkelsen RB, Park CC, Weidhaas JB, Zietman AL, Steinberg M.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):11-7. doi: 10.1016/j.ijrobp.2013.09.040. Epub 2013 Nov 15. Erratum in: Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1115.

PMID:
24246724
37.

Semi-automatic segmentation of subcutaneous tumours from micro-computed tomography images.

Ali R, Gunduz-Demir C, Szilágyi T, Durkee B, Graves EE.

Phys Med Biol. 2013 Nov 21;58(22):8007-19. doi: 10.1088/0031-9155/58/22/8007. Epub 2013 Oct 30.

38.

Understanding the contribution of habitats and regional variation to long-term population trends in tricolored blackbirds.

Graves EE, Holyoak M, Rodd Kelsey T, Meese RJ.

Ecol Evol. 2013 Sep;3(9):2845-58. doi: 10.1002/ece3.681. Epub 2013 Jul 22.

39.

Targeted therapies and hypoxia imaging.

Ali R, Graves EE.

Q J Nucl Med Mol Imaging. 2013 Sep;57(3):283-95. Review.

PMID:
24045624
40.

PET imaging of stroke-induced neuroinflammation in mice using [18F]PBR06.

Lartey FM, Ahn GO, Shen B, Cord KT, Smith T, Chua JY, Rosenblum S, Liu H, James ML, Chernikova S, Lee SW, Pisani LJ, Tirouvanziam R, Chen JW, Palmer TD, Chin FT, Guzman R, Graves EE, Loo BW Jr.

Mol Imaging Biol. 2014 Feb;16(1):109-17. doi: 10.1007/s11307-013-0664-5. Epub 2013 Jul 9.

41.

Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy.

Sasportas LS, Hosford DN, Sodini MA, Waters DJ, Zambricki EA, Barral JK, Graves EE, Brinton TJ, Yock PG, Le QT, Sirjani D.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jul;116(1):e37-51. doi: 10.1016/j.oooo.2013.02.017. Epub 2013 May 3. Review.

42.

Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal.

Bazan JG, Koong AC, Kapp DS, Quon A, Graves EE, Loo BW Jr, Chang DT.

J Nucl Med. 2013 Jan;54(1):27-32. doi: 10.2967/jnumed.112.109470. Epub 2012 Dec 12.

43.

Monte Carlo model of the scanning beam digital x-ray (SBDX) source.

Bazalova M, Weil MD, Wilfley B, Graves EE.

Phys Med Biol. 2012 Nov 21;57(22):7381-94. doi: 10.1088/0031-9155/57/22/7381. Epub 2012 Oct 24.

44.

Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy.

Abelson JA, Murphy JD, Trakul N, Bazan JG, Maxim PG, Graves EE, Quon A, Le QT, Diehn M, Loo BW Jr.

Lung Cancer. 2012 Dec;78(3):219-24. doi: 10.1016/j.lungcan.2012.08.016. Epub 2012 Sep 23.

PMID:
23009727
45.

Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer.

Nair VS, Gevaert O, Davidzon G, Napel S, Graves EE, Hoang CD, Shrager JB, Quon A, Rubin DL, Plevritis SK.

Cancer Res. 2012 Aug 1;72(15):3725-34. doi: 10.1158/0008-5472.CAN-11-3943. Epub 2012 Jun 18. Erratum in: Cancer Res. 2012 Sep 15;72(18):4870-1.

46.

Molecular Imaging of Hypoxia: Strategies for Probe Design and Application.

Apte S, Chin FT, Graves EE.

Curr Org Synth. 2011 Aug;8(4):593-603.

47.

Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.

Naidoo V, Karanian DA, Vadivel SK, Locklear JR, Wood JT, Nasr M, Quizon PM, Graves EE, Shukla V, Makriyannis A, Bahr BA.

Neurotherapeutics. 2012 Oct;9(4):801-13. doi: 10.1007/s13311-011-0100-y.

48.

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

Tang C, Murphy JD, Khong B, La TH, Kong C, Fischbein NJ, Colevas AD, Iagaru AH, Graves EE, Loo BW Jr, Le QT.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1514-20. doi: 10.1016/j.ijrobp.2011.10.023. Epub 2012 Jan 21.

49.

Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes.

Chu KP, Murphy JD, La TH, Krakow TE, Iagaru A, Graves EE, Hsu A, Maxim PG, Loo B, Chang DT, Le QT.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1521-7. doi: 10.1016/j.ijrobp.2011.10.022. Epub 2012 Jan 21.

50.

Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease.

Tseng D, Rachakonda LP, Su Z, Advani R, Horning S, Hoppe RT, Quon A, Graves EE, Loo BW Jr, Tran PT.

Radiat Oncol. 2012 Jan 19;7:5. doi: 10.1186/1748-717X-7-5.

Supplemental Content

Loading ...
Support Center